Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: a multicentre observational study.
Qiuhe Wang,Dongdong Xia,Wei Bai,Enxin Wang,Junhui Sun,Ming Huang,Wei Mu,Guowen Yin,Hailiang Li,Hui Zhao,Jing Li,Chunqing Zhang,Xiaoli Zhu,Jianbing Wu,Jiaping Li,Weidong Gong,Zixiang Li,Zhengyu Lin,Xingnan Pan,Haibin Shi,Guoliang Shao,Jueshi Liu,Shufa Yang,Yanbo Zheng,Jian Xu,Jinlong Song,Wenhui Wang,Zhexuan Wang,Yuelin Zhang,Rong Ding,Hui Zhang,Hui Yu,Lin Zheng,Weiwei Gu,Nan You,Guangchuan Wang,Shuai Zhang,Long Feng,Lin Liu,Peng Zhang,Xueda Li,Jian Chen,Tao Xu,Weizhong Zhou,Hui Zeng,Yongjin Zhang,Wukui Huang,Wenjin Jiang,Wen Zhang,Wenbo Shao,Lei Li,Jing Niu,Jie Yuan,Xiaomei Li,Yong Lv,Kai Li,Zhanxin Yin,Jielai Xia,Daiming Fan,Guohong Han
DOI: https://doi.org/10.1016/j.jhep.2019.01.013
IF: 25.7
2019-01-01
Journal of Hepatology
Abstract:•First prognostic model specifically developed for ideal TACE candidates.•The individualized prediction score is presented as the sum of tumour size (cm) and number.•With cut-offs of 6 and 12, the score can stratify these patients into 3 prognostic strata.•The score outperformed other available models in performance and discrimination.•The score is advantageous for easy-to-use and individualized prediction.